Phase I, multi-center, open-label, dose-escalation study of pasireotide LAR (PAS) in patients with advanced neuroendocrine tumors (NET)
Autor: | Madan G. Kundu, Jennifer A. Chan, Edward M. Wolin, Mike Hu, Jonathan R. Strosberg, Sue-zette Valera, Christelle Darstein, James C. Yao, Alain C. Mita, Peter Unge |
---|---|
Rok vydání: | 2016 |
Předmět: | |
Zdroj: | Journal of Clinical Oncology. 34:4095-4095 |
ISSN: | 1527-7755 0732-183X |
Popis: | 4095Background: Pasireotide, a novel somatostatin analog, has been previously investigated but the maximum tolerated dose (MTD) has not been determined in pts with advanced NET. We report results o... |
Databáze: | OpenAIRE |
Externí odkaz: |